0.06
price down icon4.15%   -0.0026
pre-market  시장 영업 전:  .06  
loading

Eyenovia Inc 주식(EYEN)의 최신 뉴스

pulisher
Jan 20, 2025

Financial Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) & Eyenovia (NASDAQ:EYEN) - Defense World

Jan 20, 2025
pulisher
Jan 17, 2025

Eyenovia secures $1 million from warrant repricing and exercise - MSN

Jan 17, 2025
pulisher
Jan 16, 2025

Eyenovia secures $1 million from warrant repricing and exercise By Investing.com - Investing.com Canada

Jan 16, 2025
pulisher
Jan 16, 2025

SEC Form 424B3 filed by Eyenovia Inc. - Quantisnow

Jan 16, 2025
pulisher
Jan 15, 2025

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote 'FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - The Manila Times

Jan 15, 2025
pulisher
Jan 15, 2025

Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire

Jan 15, 2025
pulisher
Jan 15, 2025

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewswire Inc.

Jan 15, 2025
pulisher
Jan 14, 2025

Ladenburg Thalmann Downgrades Eyenovia (EYEN) - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

Geode Capital Management LLC Increases Stock Position in Eyenovia, Inc. (NASDAQ:EYEN) - Defense World

Jan 14, 2025
pulisher
Jan 10, 2025

Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block - Benzinga

Jan 10, 2025
pulisher
Jan 09, 2025

Mydriasis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight - The Globe and Mail

Jan 09, 2025
pulisher
Jan 09, 2025

Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail

Jan 09, 2025
pulisher
Jan 09, 2025

Eyenovia Eyes Cost-Cutting Measures Amid Disappointing Study Results - MPO-mag

Jan 09, 2025
pulisher
Jan 09, 2025

Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA - openPR

Jan 09, 2025
pulisher
Jan 06, 2025

Eyenovia explores strategic alternatives, advances Optejet device By Investing.com - Investing.com Nigeria

Jan 06, 2025
pulisher
Jan 06, 2025

Eyenovia Hires Financial Adviser Amid Business Review - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewswire

Jan 06, 2025
pulisher
Jan 06, 2025

Eyenovia explores strategic alternatives, advances Optejet device - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans - StockTitan

Jan 06, 2025
pulisher
Jan 02, 2025

Eyenovia (NASDAQ:EYEN) Enters into Amended and Restated Sales Agreement with Chardan Capital Markets, LLC - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Dec 31, 2024
pulisher
Dec 30, 2024

SEC Form 424B5 filed by Eyenovia Inc. - Quantisnow

Dec 30, 2024
pulisher
Dec 16, 2024

Eyenovia faces Nasdaq delisting over low stock price By Investing.com - Investing.com Nigeria

Dec 16, 2024
pulisher
Dec 15, 2024

Eyenovia faces Nasdaq delisting over low stock price - Investing.com

Dec 15, 2024
pulisher
Dec 10, 2024

Eyenovia (NASDAQ:EYEN) Announces Completion of Registered Direct Offering - Defense World

Dec 10, 2024
pulisher
Dec 09, 2024

Eyenovia’s $1.9M Offering to Boost Optejet Development - TipRanks

Dec 09, 2024
pulisher
Dec 09, 2024

Form 424B5 EYENOVIA, INC. - StreetInsider.com

Dec 09, 2024
pulisher
Dec 07, 2024

Eyenovia announces pricing of $1.9M registered direct offering - MSN

Dec 07, 2024
pulisher
Dec 07, 2024

Eyenovia secures $1.9 million in direct offering By Investing.com - Investing.com Canada

Dec 07, 2024
pulisher
Dec 06, 2024

Eyenovia secures $1.9 million in direct offering - Investing.com

Dec 06, 2024
pulisher
Dec 06, 2024

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewswire

Dec 06, 2024
pulisher
Dec 06, 2024

Eyenovia Announces $1.9M Direct Offering to Fund Optejet Development, Strategic Growth - StockTitan

Dec 06, 2024
pulisher
Dec 02, 2024

These Numbers Show Just How Powerful Eyenovia Inc (NASDAQ: EYEN) Stock ‎Is - Stocks Register

Dec 02, 2024
pulisher
Nov 29, 2024

Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update - Defense World

Nov 29, 2024
pulisher
Nov 26, 2024

Eyenovia’s Direct Offering to Support Strategic Initiatives - TipRanks

Nov 26, 2024
pulisher
Nov 26, 2024

Eyenovia secures $1.3 million in direct offering By Investing.com - Investing.com South Africa

Nov 26, 2024
pulisher
Nov 25, 2024

Eyenovia defers loan payments, issues equity to lenders - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

Eyenovia defers loan payments, issues equity to lenders By Investing.com - Investing.com Canada

Nov 25, 2024
pulisher
Nov 25, 2024

Eyenovia Slumps On Pricing Of Registered Direct Offering - Nasdaq

Nov 25, 2024
pulisher
Nov 25, 2024

Eyenovia Restructures Finances and Leadership Team - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering - The Manila Times

Nov 25, 2024
pulisher
Nov 25, 2024

Eyenovia secures $1.3 million in direct offering - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

Eyenovia Raises $1.3M in Direct Offering at $0.1076 Per Share with Warrants | EYEN Stock News - StockTitan

Nov 25, 2024
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
자본화:     |  볼륨(24시간):